Iron deficiency (ID) is common in patients with cardiovascular disease. Up to 60% of patients
with coronary artery disease, and an even higher proportion of those with heart failure (HF) …

Iron deficiency affects up to one-third of the world's population, and is particularly common in
elderly individuals and those with certain chronic diseases. Iron excess can be detrimental …

Iron deficiency (ID) is one of the most frequent comorbidities in patients with heart failure
(HF). ID is estimated to be present in up to 50% of outpatients and is a strong independent …

Aims Iron deficiency is common in patients with heart failure (HF) and reduced ejection
fraction (HFrEF) and is associated with a poor prognosis. Whether intravenous iron …

Abstract Background and Aims Whereas a beneficial effect of intravenous ferric
carboxymaltose (FCM) on symptoms and exercise capacity among patients with iron …

Iron deficiency is a major heart failure co‐morbidity present in about 50% of patients with
stable heart failure irrespective of the left ventricular function. Along with compromise of daily …

Aims Iron deficiency (ID) is a common co‐morbidity in patients with heart failure (HF) and
has been suggested to be associated with poor prognosis. Recently completed double …

Aims Beyond erythropoiesis, iron is involved in numerous biological processes crucial for
maintenance of homeostasis. Patients with chronic heart failure (CHF) are prone to develop …

Iron deficiency is an extremely common comorbidity in patients with heart failure, affecting
up to 50% of all ambulatory patients. It is associated with reduced exercise capacity and …

Aims For patients with heart failure (HF) and iron deficiency (ID), randomized trials suggest
that intravenous (IV) iron reduces hospitalizations for heart failure (HHF), but uncertainty …